Abstract
This article is devoted to the problem of survival and prognosis of treatment outcomes of patients with traumatic brain injury who have sustained craniocerebral trauma according to changes in neurospecific protein (S100β) levels during the acute period of trauma. The material includes data from the examination of 250 combatants and invalids who sustained craniocerebral trauma in the ATO-JFO zone at the neurological department of the Regional Hospital for War Veterans. An analysis of the course and results of treatment of patients who had sustained severe craniocerebral trauma was carried out. Patients underwent routine biochemical examinations, neuroimaging studies and neurospecific protein (S100β) levels examination in the acute period of trauma. On the basis of the data obtained, it was found that the level of neurospecific protein S100β in the blood serum takes a great role in predicting the course and outcome of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Clinical and Experimental Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
